<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29008" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Shwachman-Diamond Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Farooqui</surname>
            <given-names>Samid M.</given-names>
          </name>
          <aff>Un of Oklahoma Health Sciences Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ward</surname>
            <given-names>Rebecca</given-names>
          </name>
          <aff>University of Florida</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aziz</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>University of Toledo Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Samid Farooqui declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rebecca Ward declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Aziz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29008.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Schwachman-Diamond syndrome (SDS) is an autosomal recessive disorder that is the second most common cause of exocrine pancreatic insufficiency after cystic fibrosis. It presents with the common triad of exocrine pancreatic dysfunction, skeletal abnormalities, and bone marrow dysfunction. However, cardiac abnormalities, immune dysfunction, and hematologic disorders are also reported. A mutation in the Shwachman-Bodian-Diamond syndrome (SBDS) gene on chromosome 7 is found in 90% of the cases. This activity reviews the clinical presentation, diagnostic workup, management, and potential complications of this disorder and highlights the role of the interprofessional team in caring for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the etiology of Schwachman-Diamond syndrome.</p></list-item><list-item><p>Review the evaluation for Schwachman-Diamond syndrome.</p></list-item><list-item><p>Outline the treatment and management options available for Schwachman-Diamond syndrome.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance care for patients with Schwachman-Diamond syndrome and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29008&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29008">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29008.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Schwachman-Diamond syndrome (SDS) is an autosomal recessive disorder that is the second most common cause of exocrine pancreatic insufficiency after cystic fibrosis.&#x000a0;It presents with the common triad of exocrine pancreatic dysfunction, skeletal abnormalities, and bone marrow dysfunction. However, cardiac abnormalities, immune dysfunction, and hematologic disorders are also reported.&#x000a0;A mutation in the Shwachman-Bodian-Diamond syndrome<italic toggle="yes"> (SBDS) </italic>gene on chromosome 7 is found in 90% of the cases.<xref ref-type="bibr" rid="article-29008.r1">[1]</xref><xref ref-type="bibr" rid="article-29008.r2">[2]</xref><xref ref-type="bibr" rid="article-29008.r3">[3]</xref><xref ref-type="bibr" rid="article-29008.r4">[4]</xref></p>
      </sec>
      <sec id="article-29008.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>SDS is caused by an <italic toggle="yes">SBDS</italic> gene mutation on chromosome 7. It codes for the SBDS protein (SBDSP), which is widely expressed, throughout the body, in different organ systems. <italic toggle="yes">SBDS</italic> gene and <italic toggle="yes">SBDSP</italic> pseudogene are located in proximity on chromosome 7, and a possible conversion event between the 2 loci result in the mutation.<xref ref-type="bibr" rid="article-29008.r5">[5]</xref><xref ref-type="bibr" rid="article-29008.r6">[6]</xref><xref ref-type="bibr" rid="article-29008.r7">[7]</xref></p>
      </sec>
      <sec id="article-29008.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It is a rare disorder with a reported incidence of 1 in 75,000 individuals. Patients generally present in infancy. Life expectancy into the third and fourth decades of life is reported in the literature. There is a higher incidence of males affected with a male to female ratio of 1.7:1.</p>
      </sec>
      <sec id="article-29008.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">SBDS</italic> gene codes for the SBDS protein. The protein is found predominantly in the nucleolus and is implicated in the normal functioning of ribosomes, amplification of the centrosomes, and in leukemogenesis. However, the true function of the SBDS protein is still unknown.&#x000a0;In the pancreas, there is the fatty replacement of the acinar cells, which results in an exocrine deficiency.&#x000a0;Cytopenias result in stress hematopoiesis in the bone marrow, which accounts for the elevated levels of hemoglobin F. The exact mechanism behind malignant transformation into acute myelogenous leukemia (AML) is unknown.&#x000a0; The abnormalities in the hematological system may be absent on initial presentation but can manifest later as part of an evolving process.<xref ref-type="bibr" rid="article-29008.r8">[8]</xref><xref ref-type="bibr" rid="article-29008.r9">[9]</xref><xref ref-type="bibr" rid="article-29008.r10">[10]</xref></p>
      </sec>
      <sec id="article-29008.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>SDS is thought to be underdiagnosed in the general population due to its ambiguous presentation. It can present at any time in life, though most cases present earlier in life. Predominantly, patients present with exocrine pancreatic insufficiency and hematologic abnormalities; other manifestations are less common.&#x000a0;Steatorrhea, malabsorption, and deficiency of fat-soluble vitamins are the hallmarks of exocrine pancreatic insufficiency; however, most of these symptoms improve with age in most patients.</p>
        <p>Hematologic abnormalities are also common in patients with SDS. Leukopenia results in recurrent viral and bacterial infections, including but not limited to sinusitis, pneumonia, osteomyelitis, and septicemia. Patients can present with bleeding, sometimes life-threatening, due to thrombocytopenia. Macrocytic or normocytic anemia is also seen in up to 80% of patients.&#x000a0;&#x000a0;</p>
        <p>Patients can also present with manifestations of skeletal abnormalities. These include short stature, rib-cage abnormalities, slipped femoral epiphysis, spinal, and finger deformities.</p>
        <p>Neurological abnormalities, including intellectual disability, depressed attention span, difficulty in executive functioning, and impaired visual motor coordination, can also be present. Behavioral changes are also reported in children with SDS.</p>
      </sec>
      <sec id="article-29008.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Presence of hematological abnormalities and exocrine pancreatic insufficiency are needed to make a clinical diagnosis of SDS, according to the latest guidelines. However, other causes of bone marrow failure and exocrine pancreatic insufficiency should be excluded.</p>
        <p>Patients with suspected exocrine pancreatic insufficiency should have a 72-hour stool fat quantification test performed. Trypsinogen and isoamylase levels aid in the diagnosis; however, trypsinogen levels can only be measured before three years of age as levels start&#x000a0;increasing after three years; whereas, isoamylase levels always remain low. A sweat chloride test is normal in these patients, and this distinguishes between SDS and cystic&#x000a0;fibrosis.</p>
        <p>Routine blood workup can provide information about cytopenias. Patients with SDS need frequent monitoring of blood for early detection of progression to myelodysplastic syndromes or acute myelogenous leukemia (AML).&#x000a0;</p>
        <p>Genetic testing for mutations of the <italic toggle="yes">SBDS</italic> gene can confirm the diagnosis in 90% of the cases. Upon confirmation of diagnosis, a bone marrow biopsy, aspirate smear, cytological testing, and a skeletal survey is recommended.</p>
        <p>Referral to a specialist should be made if any neurocognitive deficit is suspected.</p>
      </sec>
      <sec id="article-29008.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Upon confirmation of diagnosis, patients should be initiated on a pancreatic enzymatic replacement. This is shown to generate a good response in these patients. Levels of fat-soluble vitamins should also be checked regularly (every 6 to 12 months) and replaced as necessary. The exocrine pancreatic function should be checked as it improves with time, and enzymatic replacement may need to be discontinued. Additionally, patients should have dietary counseling provided by a certified dietitian with regular monitoring of growth by serial height and weight measurements.</p>
        <p>Transfusions of packed red blood cells (PRBC) and platelets are the mainstay of management for anemia and thrombocytopenia, respectively. In patients requiring extensive PRBC transfusions, initiation of iron chelation needs to be considered.</p>
        <p>Infections are the feared complication of leukopenia. Prompt treatment with antibiotics is the mainstay of therapy. Granulocyte colony-stimulating&#x000a0;factor (G-CSF) can be used to increase the white blood cell (WBC) count. However, it is not needed in most patients. It can be used in patients with severe neutropenia or patients with frequent invasive infections. The goal of G-CSF administration is to reduce the incidence of infections and not to achieve normal laboratory hematological values. There is some concern about G-CSF use causing myelodysplastic and leukemic transformation in the bone marrow, but there is a lack of strong evidence to prove it.</p>
        <p>Patients should have routine blood monitoring every 3 to 4 months with a hematologist for detection of marrow failure, myelodysplastic syndrome, or leukemia. Due to the rarity of the disease, there is no particular chemotherapeutic regimen approved for these patients. Chemotherapy only serves to contain the disease process and is not curative in SDS patients with leukemia. Hematopoietic stem cell transplant (HSCT) is the only curative treatment in these patients. The indication for receiving HSCT determines survival. Patients receiving HSCT for bone marrow failure (e.g., aplastic anemia) have been reported to fare better than patients receiving HSCT for leukemia.</p>
        <p>Patients with SDS are more likely to have complications from chemotherapy and HSCT than patients with isolated hematological problems requiring similar treatments. These include infections, persistent aplasia, cardiotoxicity, and renal failure.</p>
        <p>Follow-up of the skeletal system is determined by the findings of the initial skeletal survey performed at the time of diagnosis. Patients with SDS should be monitored for osteoporosis. Vitamin D levels should be checked and maintained within normal limits.</p>
        <p>Patients with SDS should have regular developmental neuropsychological evaluations from ages 5 to 18 to assess for adequate brain maturation.</p>
      </sec>
      <sec id="article-29008.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Cystic fibrosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pearson syndrome&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pancreatic agenesis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Johanson-Blizzard syndrome&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cartilage-hair hypoplasia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29008.s10" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Hematology/oncology&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Gastroenterology&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Orthopedic surgery&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Psychologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29008.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>SDS is a rare blood disorder associated with pancreatic insufficiency. It is best managed by an interprofessional team that includes hematology nurses. There is no cure for this disorder and treatment is required in most patients. Unfortunately, the treatments do have adverse effects that are not well tolerated. Once a diagnosis of SDS is made, a genetic consult should be made for the rest of the family,&#x000a0;</p>
        <p>The outcomes for patients with SDS are guarded.</p>
      </sec>
      <sec id="article-29008.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29008&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29008">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/shwachman-diamond-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29008">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29008/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29008">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29008.s13">
        <title>References</title>
        <ref id="article-29008.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kermasson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hoslin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jaako</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Faille</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Acevedo-Arozena</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lengline</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ranta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Poir&#x000e9;e</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fenneteau</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ducou le Pointe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fumagalli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beaupain</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nitschk&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>B&#x000f4;le-Feysot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de Villartay</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bellann&#x000e9;-Chantelot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Donadieu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kannengiesser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Revy</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.</article-title>
            <source>Blood</source>
            <year>2019</year>
            <month>Jul</month>
            <day>18</day>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>277</fpage>
            <page-range>277-290</page-range>
            <pub-id pub-id-type="pmid">31151987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szabo</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Man</surname>
                <given-names>OI</given-names>
              </name>
              <name>
                <surname>&#x0015e;erban</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kiss</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Laz&#x00103;r</surname>
                <given-names>CF</given-names>
              </name>
            </person-group>
            <article-title>Bruising as the first sign of exocrine pancreatic insufficiency in infancy.</article-title>
            <source>Med Pharm Rep</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>200</fpage>
            <page-range>200-204</page-range>
            <pub-id pub-id-type="pmid">31086851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Phyu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaewwanna</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Decreased accumulation of superoxide dismutase 2 within mitochondria in the yeast model of Shwachman-Diamond syndrome.</article-title>
            <source>J Cell Biochem</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>120</volume>
            <issue>8</issue>
            <fpage>13867</fpage>
            <page-range>13867-13880</page-range>
            <pub-id pub-id-type="pmid">30938873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cipolli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tridello</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Micheletto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perobelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pintani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cesaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maserati</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nicolis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Danesino</surname>
                <given-names>C</given-names>
              </name>
              <collab>Italian Registry Organization</collab>
            </person-group>
            <article-title>Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old.</article-title>
            <source>BMJ Open</source>
            <year>2019</year>
            <month>Jan</month>
            <day>17</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>e022617</fpage>
            <pub-id pub-id-type="pmid">30782681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kallen</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Dulau-Florea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Calvo</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.</article-title>
            <source>Semin Hematol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-82</page-range>
            <pub-id pub-id-type="pmid">30573048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bezzerri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cipolli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.</article-title>
            <source>Mol Diagn Ther</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>281</fpage>
            <page-range>281-290</page-range>
            <pub-id pub-id-type="pmid">30413969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome.</article-title>
            <source>Hematol Oncol Clin North Am</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>687</fpage>
            <page-range>687-700</page-range>
            <pub-id pub-id-type="pmid">30047420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ong</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>AYL</given-names>
              </name>
              <name>
                <surname>Nagarajan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ngeow</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Delayed diagnosis of Shwachman diamond syndrome with short telomeres and a review of cases in Asia.</article-title>
            <source>Leuk Res Rep</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>54</fpage>
            <page-range>54-57</page-range>
            <pub-id pub-id-type="pmid">29892551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Farooqui</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Shwachman-Diamond Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">29939643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29008.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Nelson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Shwachman-Diamond Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2008</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">20301722</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
